المساهمون: Nehal J Lakhani, Laura Q M Chow, Justin F Gainor, Patricia LoRusso, Keun-Wook Lee, Hyun Cheol Chung, Jeeyun Lee, Yung-Jue Bang, Frank Stephen Hodi, Won Seog Kim, Rafael Santana-Davila, Philip Fanning, Pierre Squifflet, Feng Jin, Tracy C Kuo, Hong I Wan, Jaume Pons, Sophia S Randolph, Wells A Messersmith, Chung, Hyun Cheol

مصطلحات موضوعية: Aged, Antibodies, Monoclonal, Humanized / administration & dosage, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Female, Follow-Up Studies, Humans, Immunoglobulin Fc Fragments / administration & dosage, Male, Maximum Tolerated Dose, Middle Aged, Neoplasms / drug therapy, Neoplasms / pathology, Prognosis, Trastuzumab / administration & dosage

العلاقة: LANCET ONCOLOGY; J02154; OAK-2022-05350; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191105Test; https://www.sciencedirect.com/science/article/pii/S1470204521005842Test; T999202267; LANCET ONCOLOGY, Vol.22(12) : 1740-1751, 2021-12

الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00584-2
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191105Test
https://www.sciencedirect.com/science/article/pii/S1470204521005842Test

المساهمون: Chihwan Cha, Sung Gwe Ahn, Dooreh Kim, Janghee Lee, Soeun Park, Soong June Bae, Jee Ye Kim, Hyung Seok Park, Seho Park, Seung Il Kim, Byeong-Woo Park, Joon Jeong, Kim, Seung Il

مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized / administration & dosage, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Axilla, Biomarkers, Tumor, Breast Neoplasms / drug therapy, Breast Neoplasms / metabolism, Breast Neoplasms / pathology, Female, Follow-Up Studies, Gene Expression Regulation, Neoplastic, Humans, Lymph Nodes / metabolism, Lymph Nodes / pathology, Lymphatic Metastasis, Middle Aged, Neoadjuvant Therapy / methods, Prognosis, Receptor, ErbB-2 / antagonists & inhibitors, ErbB-2 / metabolism, Retrospective Studies, Survival Rate, Trastuzumab / administration & dosage

العلاقة: INTERNATIONAL JOURNAL OF CANCER; J01092; OAK-2021-05851; https://ir.ymlib.yonsei.ac.kr/handle/22282913/185374Test; T202103587; INTERNATIONAL JOURNAL OF CANCER, Vol.149(8) : 1585-1592, 2021-10

الإتاحة: https://doi.org/10.1002/ijc.33726Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/185374Test

المؤلفون: Murthy, R. K., Loi, S., Okines, A., Paplomata, E., Hamilton, E., Hurvitz, S. A., Lin, N. U., Borges, V., Abramson, V., Anders, C., Bedard, P. L., Oliveira, M., Jakobsen, E., Bachelot, T., Shachar, S. S., Muller, V., Braga, S., Duhoux, F. P., Greil, R., Cameron, D., Carey, L. A., Curigliano, G., Gelmon, K., Hortobagyi, G., Krop, I., Loibl, S., Pegram, M., Slamon, D., Palanca-Wessels, M. C., Walker, L., Feng, W., Winer, E. P.

المصدر: Murthy , R K , Loi , S , Okines , A , Paplomata , E , Hamilton , E , Hurvitz , S A , Lin , N U , Borges , V , Abramson , V , Anders , C , Bedard , P L , Oliveira , M , Jakobsen , E , Bachelot , T , Shachar , S S , Muller , V , Braga , S , Duhoux , F P , Greil , R , Cameron , D , Carey , L A , Curigliano , G , Gelmon , K , ....

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Brain Neoplasms/secondary, Breast Neoplasms/drug therapy, Capecitabine/administration & dosage, Consolidation Chemotherapy, Diarrhea/chemically induced, Double-Blind Method, Female, Humans, Kaplan-Meier Estimate, Middle Aged, Progression-Free Survival, Protein-Tyrosine Kinases/antagonists & inhibitors, Receptor, ErbB-2/analysis, Trastuzumab/administration & dosage

وصف الملف: application/pdf

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/68464b3b-6eae-4ed1-9926-219625af6304Test

الإتاحة: https://doi.org/10.1056/NEJMoa1914609Test
https://portal.findresearcher.sdu.dk/da/publications/68464b3b-6eae-4ed1-9926-219625af6304Test
https://findresearcher.sdu.dk/ws/files/170528833/NEJMoa1914609.pdfTest

المؤلفون: Henderson, Shelley A., Muhammad Gowdh, Naleen, Purdie, Colin A., Jordan, Lee B., Evans, Andrew, Brunton, Tracy, Thompson, Alastair M., Vinnicombe, Sarah

المصدر: Henderson , S A , Muhammad Gowdh , N , Purdie , C A , Jordan , L B , Evans , A , Brunton , T , Thompson , A M & Vinnicombe , S 2018 , ' Breast cancer : influence of tumour volume estimation method at MRI on prediction of pathological response to neoadjuvant chemotherapy ' , British Journal of Radiology , vol. 91 , no. 1087 , 20180123 , pp. 1-9 . https://doi.org/10.1259/bjr.20180123Test

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms/diagnostic imaging, Contrast Media, Cyclophosphamide/administration & dosage, Epirubicin/administration & dosage, Female, Fluorouracil/administration & dosage, Humans, Image Interpretation, Computer-Assisted/methods, Magnetic Resonance Imaging/methods, Meglumine, Middle Aged, Neoadjuvant Therapy, Organometallic Compounds, Predictive Value of Tests, Reproducibility of Results, Retrospective Studies, Taxoids/administration & dosage, Trastuzumab/administration & dosage, Treatment Outcome, Tumor Burden, /dk/atira/pure/subjectarea/asjc/2700/2741, name=Radiology Nuclear Medicine and imaging

وصف الملف: application/pdf

العلاقة: https://discovery.dundee.ac.uk/en/publications/cbafc26e-fd02-402c-894b-15557eb01326Test

الإتاحة: https://doi.org/10.1259/bjr.20180123Test
https://discovery.dundee.ac.uk/en/publications/cbafc26e-fd02-402c-894b-15557eb01326Test
https://discovery.dundee.ac.uk/ws/files/27802656/bjr.20180123.pdfTest

المساهمون: Others, Hye Duck Choi, Min Jung Chang

مصطلحات موضوعية: Antineoplastic Agents / administration & dosage, Antineoplastic Agents / adverse effects, Breast Neoplasms / drug therapy, Breast Neoplasms / genetics, Breast Neoplasms / pathology, Cardiotoxicity / pathology, ErbB Receptors / genetics, Female, Heart / drug effects, Heart / physiopathology, Humans, Lapatinib, Protein Kinase Inhibitors / administration & dosage, Protein Kinase Inhibitors / adverse effects, Quinazolines / administration & dosage, Quinazolines / adverse effects, Receptor, ErbB-2 / genetics, Trastuzumab / administration & dosage, Trastuzumab / adverse effects, Ventricular Dysfunction, Left / chemically induced, Left / physiopathology, Cardiac toxicity, Meta-analysis

العلاقة: BREAST CANCER RESEARCH AND TREATMENT; J00403; OAK-2017-1059; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195639Test; https://link.springer.com/article/10.1007/s10549-017-4460-9Test; T999201748; BREAST CANCER RESEARCH AND TREATMENT, Vol.166(3) : 927-936, 2017-12

الإتاحة: https://doi.org/10.1007/s10549-017-4460-9Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/195639Test

المساهمون: College of Medicine, Dept. of Radiology, Choong-Kun Lee, Seung-Seob Kim, Saemi Park, Chan Kim, Su Jin Heo, Joon Seok Lim, Hyunki Kim, Hyo Song Kim, Sun Young Rha, Hyun Cheol Chung, Sohee Park, Minkyu Jung, Kim, Seung Seob, Kim, Hyun Ki, Kim, Hyo Song, Rha, Sun Young, Lee, Choong Kun, Lim, Joon Seok, Jung, Min Kyu, Chung, Hyun Cheol, Heo, Su Jin, Park, So Hee

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Agents, Immunological/administration & dosage, Immunological/adverse effects, Immunological/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biomarkers, Tumor, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Prognosis, ROC Curve, Stomach Neoplasms/diagnosis, Stomach Neoplasms/drug therapy, Stomach Neoplasms/mortality, Trastuzumab/administration & dosage, Trastuzumab/adverse effects, Trastuzumab/therapeutic use, Treatment Outcome, depth of response, early tumor shrinkage, gastric cancer

العلاقة: ONCOTARGET; J02421; OAK-2017-02183; https://ir.ymlib.yonsei.ac.kr/handle/22282913/153668Test; T201701509; ONCOTARGET , Vol.8(19) : 31169-31179, 2017; 42963

الإتاحة: https://doi.org/10.18632/oncotarget.16099Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/153668Test

المساهمون: Patrick G Gavin, Nan Song, S Rim Kim, Corey Lipchik, Nicole L Johnson, Hanna Bandos, Melanie Finnigan, Priya Rastogi, Louis Fehrenbacher, Eleftherios P Mamounas, Sandra M Swain, D Lawrence Wickerham, Charles E Geyer Jr, Jong-Hyeon Jeong, Joseph P Costantino, Norman Wolmark, Soonmyung Paik, Kay L Pogue-Geile, Paik, Soon Myung

مصطلحات موضوعية: Antineoplastic Agents / administration & dosage, Antineoplastic Agents / therapeutic use, Breast Neoplasms / drug therapy, Breast Neoplasms / genetics, Breast Neoplasms / metabolism, Chemotherapy, Adjuvant, Female, Humans, Pharmacogenomic Variants, Polymorphism, Single Nucleotide, Receptor, ErbB-2 / metabolism, Receptors, IgG / genetics, Survival Analysis, Trastuzumab / administration & dosage, Trastuzumab / therapeutic use

العلاقة: JAMA ONCOLOGY; J02919; OAK-2020-02130; https://ir.ymlib.yonsei.ac.kr/handle/22282913/178330Test; T201706256; JAMA ONCOLOGY, Vol.3(3) : 335-341, 2017-03

الإتاحة: https://doi.org/10.1001/jamaoncol.2016.4884Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/178330Test

المؤلفون: Dennis J. Slamon, Thomas Bachelot, Erik Jakobsen, Rashmi Krishna Murthy, Alicia Okines, David Cameron, Lisa A. Carey, Giuseppe Curigliano, Ian E. Krop, Karen A. Gelmon, Volkmar Müller, Nan Lin, Virginia F. Borges, Eric P. Winer, Gabriel N. Hortobagyi, Philippe L. Bedard, Richard Greil, Sara A. Hurvitz, François Duhoux, Luke Walker, Sofia Braga, Elisavet Paplomata, M Corinna Palanca-Wessels, Sherene Loi, Vandana G. Abramson, Mafalda Oliveira, Carey K. Anders, Wentao Feng, Mark D. Pegram, Shlomit S. Shachar, Sibylle Loibl, Erika Hamilton

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer

المصدر: K Murthy, R, Loi, S, Okines, A, Paplomata, E, Hamilton, E, A. Hurvitz, S, U. Lin, N, Borges, V, Abramson, V, Anders, C, L. Bedard, P, Oliveira, M, Jakobsen, E, Bachelot, T, S. Shachar, S, Müller, V, Braga, S, P. Duhoux, F, Greil, R, Cameron, D, A. Carey, L, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & P. Winer, E 2020, ' Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer ', New England Journal of Medicine, vol. 382, no. 7, pp. 597-609 . https://doi.org/10.1056/NEJMoa1914609Test
Murthy, R K, Loi, S, Okines, A, Paplomata, E, Hamilton, E, Hurvitz, S A, Lin, N U, Borges, V, Abramson, V, Anders, C, Bedard, P L, Oliveira, M, Jakobsen, E, Bachelot, T, Shachar, S S, Muller, V, Braga, S, Duhoux, F P, Greil, R, Cameron, D, Carey, L A, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & Winer, E P 2020, ' Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer ', New England Journal of Medicine, vol. 382, no. 7, pp. 597-609 . https://doi.org/10.1056/NEJMoa1914609Test
The New England journal of medicine, Vol. 382, no. 7, p. 597-609 (2020)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Protein-Tyrosine Kinases/antagonists & inhibitors, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Trastuzumab/administration & dosage, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Breast Neoplasms/drug therapy, Double-Blind Method, Trastuzumab, Internal medicine, medicine, Humans, 030212 general & internal medicine, Progression-free survival, skin and connective tissue diseases, neoplasms, Human Epidermal Growth Factor Receptor 2, Aged, integumentary system, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Disease progression, Consolidation Chemotherapy, General Medicine, Middle Aged, medicine.disease, Metastatic breast cancer, Progression-Free Survival, Multicenter study, Capecitabine/administration & dosage, Receptor, ErbB-2/analysis, Brain Neoplasms/secondary, Diarrhea/chemically induced, Female, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5309a1bc026281d5d475def4ba6ca36Test
https://www.pure.ed.ac.uk/ws/files/125147047/NEJMoa1914609.pdfTest

المؤلفون: Blackwell, K.L., Zaman, K., Qin, S., Tkaczuk, KHR, Campone, M., Hunt, D., Bryce, R., Goldstein, L.J.

المساهمون: 202 Study Group

المصدر: Clinical breast cancer, vol. 19, no. 2, pp. 97-104.e4

مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents, Immunological/administration & dosage, Immunological/adverse effects, Immunological/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Breast Neoplasms/drug therapy, Breast Neoplasms/pathology, Female, Humans, Middle Aged, Protein Kinase Inhibitors/administration & dosage, Protein Kinase Inhibitors/adverse effects, Protein Kinase Inhibitors/therapeutic use, Quinolines/administration & dosage, Quinolines/adverse effects, Quinolines/therapeutic use, Receptor, ErbB-2/antagonists & inhibitors, ErbB-2/immunology, ErbB-2/metabolism, Trastuzumab/administration & dosage, Trastuzumab/adverse effects, Trastuzumab/therapeutic use, Treatment Outcome, Young Adult, Combination drug therapy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30655172; info:eu-repo/semantics/altIdentifier/eissn/1938-0666; https://serval.unil.ch/notice/serval:BIB_AF7D20CA1A7FTest; urn:issn:1526-8209

الإتاحة: https://doi.org/10.1016/j.clbc.2018.12.011Test
https://serval.unil.ch/notice/serval:BIB_AF7D20CA1A7FTest

المؤلفون: Di Cosimo, Serena, Fumagalli, Debora, Fein, Luis Enrique L., Vinholes, Jéferson, Ng, W.M.J., Colleoni, Marco Angelo, Ferro, Antonella, Naume, Bjorn, Patel, Ashraf, Huober, Jens, Piccart-Gebhart, Martine, Campbell, Christine, Baselga, José, Azambuja, Evandro, Abdel Azim, Hatem Hamdy, Galli, Giulia, Bregni, Giacomo, Curigliano, Giuseppe, Criscitiello, Carmen, Izquierdo, Miguel, de la Peña, Lorena

المصدر: European journal of cancer, 89

مصطلحات موضوعية: Cancérologie, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Breast -- diagnostic imaging, Breast Neoplasms -- chemistry -- diagnostic imaging -- drug therapy -- mortality, Female, Humans, Lapatinib, Mammography, Middle Aged, Neoadjuvant Therapy, Quinazolines -- administration & dosage -- therapeutic use, Receptor, ErbB-2 -- analysis, Trastuzumab -- administration & dosage -- therapeutic use, Breast ultrasound, HER2 positive breast cancer, Neoadjuvant, Targeted therapy

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1016/j.ejca.2017.10.036; uri/info:pii/S0959804917313990; uri/info:pmid/29227816; uri/info:scp/85038836808; https://dipot.ulb.ac.be/dspace/bitstream/2013/263246/1/Elsevier_246873.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/263246Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/263246Test
https://dipot.ulb.ac.be/dspace/bitstream/2013/263246/1/Elsevier_246873.pdfTest